Relevant defects of platelet function in central obesity are related also to a reduced sensitivity to mediators—such as insulin, prostacyclin (PGI2), and NO—which in lean subjects reduce platelet sensitivity to proaggregating stimuli [21]. The gene discussed is INS; the disease is Abdominal obesity.